ERBB3
関連文献

“Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia”. Nat. Neurosci. 7 (6):  575–80. (2004). doi:10.1038/nn1258. PMID 15162166.
“Molecular cloning and expression of an additional epidermal growth factor receptor-related gene”. Proc. Natl. Acad. Sci. U.S.A. 87 (13):  4905–9. (1990). Bibcode: 1990PNAS...87.4905P. doi:10.1073/pnas.87.13.4905. PMC 54229. PMID 2164210. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC54229/.
“Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors”. Proc. Natl. Acad. Sci. U.S.A. 86 (23):  9193–7. (1990). doi:10.1073/pnas.86.23.9193. PMC 298460. PMID 2687875. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC298460/.
“Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas”. Oncogene 10 (9):  1813–21. (1995). PMID 7538656.
“Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3”. EMBO J. 14 (17):  4267–75. (1995). doi:10.1002/j.1460-2075.1995.tb00101.x. PMC 394510. PMID 7556068. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC394510/.
“Binding of Neu differentiation factor with the extracellular domain of Her2 and Her3”. J. Biol. Chem. 270 (41):  24604–8. (1995). doi:10.1074/jbc.270.41.24604. PMID 7592681.
“Prognostic significance of ERBB3 overexpression in oral squamous cell carcinoma”. Cancer Lett. 95 (1–2):  79–83. (1995). doi:10.1016/0304-3835(95)03866-U. PMID 7656248.
“c-erbB3 gene encodes secreted as well as transmembrane receptor tyrosine kinase”. Biochem. Biophys. Res. Commun. 192 (3):  1189–97. (1993). doi:10.1006/bbrc.1993.1542. PMID 7685162.
“Characterization of a breast cancer cell differentiation factor that specifically activates the HER4/p180erbB4 receptor”. J. Biol. Chem. 268 (25):  18407–10. (1993). doi:10.1016/S0021-9258(17)46636-1. PMID 7689552.
“High expression of the EGFR in fibroadenomas compared to breast carcinomas”. Anticancer Res. 14 (5A):  1679–88. (1995). PMID 7847801.
“Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: an immunohistochemical study”. Anticancer Res. 15 (6B):  2623–6. (1996). PMID 8669836.
“Ligands for ErbB-family receptors encoded by a neuregulin-like gene”. Nature 387 (6632):  509–12. (1997). Bibcode: 1997Natur.387R.509C. doi:10.1038/387509a0. PMID 9168114.
“Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3”. J. Biol. Chem. 273 (13):  7717–24. (1998). doi:10.1074/jbc.273.13.7717. PMID 9516479.
“Binding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis”. J. Biol. Chem. 273 (19):  11667–74. (1998). doi:10.1074/jbc.273.19.11667. PMID 9565587.
“Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues”. Oncogene 16 (25):  3243–52. (1998). doi:10.1038/sj.onc.1201866. PMID 9681822.
“Mutation of a Shc binding site tyrosine residue in ErbB3/HER3 blocks heregulin-dependent activation of mitogen-activated protein kinase”. J. Biol. Chem. 273 (33):  20996–1002. (1998). doi:10.1074/jbc.273.33.20996. PMID 9694850.
“Interaction of the p23/p198 protein with ErbB-3”. Gene 229 (1–2):  215–21. (1999). doi:10.1016/S0378-1119(98)00604-0. PMID 10095121.
“The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells”. Cancer Res. 59 (12):  2891–7. (1999). PMID 10383151.